Wednesday, July 30, 2014 8:35:15 PM
So you are saying you don't know the difference and still don't see it when people explain. We try anyway.
Given your perspective, you should find it amazingly substantial that todays problem was so incredibly minor, that it had zero influence on production. Which means.... it means zip for the products Kim said will be first to market. This PR was for higher end applications, that require a higher level of quality assurance/lower variability, for the fiber. Which means it is for the products with which Warwick Mills is interested...the ones that won't be available for quite some time. If you remember, clothing and apparel are products that will be first to market. THIS is unaffected. Which means we can go ahead and increase production, and work on quality assurance for the high end products, in the meantime. I am not amazed that KBLB can multitask like that.
You've shown you don't know what you are reading, and are prone to misidentify fluff. Kim is obviously looking at a long term view for the Monster Silk pipeline.
Someone also pointed out that Big Red is in play for this same QA(quality assurance....to spell it out) So he mentioned this same problem...and YES ahead of time, for BR. This will no doubt have good implications for the variability he mentioned we were having with BR. Fluff? Only for the near-sighted or blind.
This is precisely why I have said retail shareholders can be taken advantage of by people that know what they are doing. Not all of us are ignorant. There are more reasons this ISN"T fluff, but you need to re-read with an eye to adaptation.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM